1. Home
  2. HNNA vs ASMB Comparison

HNNA vs ASMB Comparison

Compare HNNA & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HNNA
  • ASMB
  • Stock Information
  • Founded
  • HNNA 1989
  • ASMB 2005
  • Country
  • HNNA United States
  • ASMB United States
  • Employees
  • HNNA N/A
  • ASMB N/A
  • Industry
  • HNNA Investment Managers
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • HNNA Finance
  • ASMB Health Care
  • Exchange
  • HNNA Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • HNNA 94.3M
  • ASMB 93.7M
  • IPO Year
  • HNNA N/A
  • ASMB 2010
  • Fundamental
  • Price
  • HNNA $12.44
  • ASMB $14.49
  • Analyst Decision
  • HNNA
  • ASMB Buy
  • Analyst Count
  • HNNA 0
  • ASMB 2
  • Target Price
  • HNNA N/A
  • ASMB $35.00
  • AVG Volume (30 Days)
  • HNNA 15.2K
  • ASMB 38.9K
  • Earning Date
  • HNNA 02-06-2025
  • ASMB 11-07-2024
  • Dividend Yield
  • HNNA 4.44%
  • ASMB N/A
  • EPS Growth
  • HNNA 46.17
  • ASMB N/A
  • EPS
  • HNNA 0.92
  • ASMB N/A
  • Revenue
  • HNNA $29,646,000.00
  • ASMB $28,326,000.00
  • Revenue This Year
  • HNNA N/A
  • ASMB $282.16
  • Revenue Next Year
  • HNNA N/A
  • ASMB N/A
  • P/E Ratio
  • HNNA $13.52
  • ASMB N/A
  • Revenue Growth
  • HNNA 23.42
  • ASMB N/A
  • 52 Week Low
  • HNNA $6.38
  • ASMB $9.48
  • 52 Week High
  • HNNA $13.88
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • HNNA 55.31
  • ASMB 40.72
  • Support Level
  • HNNA $11.64
  • ASMB $14.17
  • Resistance Level
  • HNNA $13.54
  • ASMB $15.73
  • Average True Range (ATR)
  • HNNA 0.65
  • ASMB 1.02
  • MACD
  • HNNA -0.06
  • ASMB -0.21
  • Stochastic Oscillator
  • HNNA 44.16
  • ASMB 8.72

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: